NFKB1 and extranodal nasal NK/T cell lymphoma: Interestingly, TNFAIP3, encoding an inhibitor of the NF-κB pathway, was underexpressed in the study, highlighting the potential involvement of the NF-κB pathway in the pathogenesis of NKTCL [15].